{"SPADE_UN_15522": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15522", "Peptide Name": "Lavracin [D2G,P3K,Y4F]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "WGKFFAGVKKLTKAILAVRA", "Sequence Length": 20, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:MEC-7 (EC50=25µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HDME:Not active up to 100 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C107H174N28O22", "Mass": 2204.7, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": 0.54, "Half Life": "Mammalian:2.8 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Rational Design of Membrane-Pore-Forming Peptides.", "Pubmed ID": "28799716", "Reference": "Small. 2017 Oct;13(40).", "Author": "Pillong M, Hiss JA, Schneider P, Lin YC, Posselt G, Pfeiffer B, Blatter M, Müller AT, Bachler S, Neuhaus CS, Dittrich PS, Altmann KH, Wessler S, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28799716"}], "Frequent Amino Acids": "AKF", "Absent Amino Acids": "CDEHMNOPQSUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 12, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_21301", "Similarity": 1.0, "Sequence": "KWGKKWGKKWGK"}, {"SPADE_ID": "SPADE_UN_01788", "Similarity": 0.8571428571428571, "Sequence": "IILAVRAVRRVR"}, {"SPADE_ID": "SPADE_UN_15524", "Similarity": 0.85, "Sequence": "WGKFFAGVKKLTKAILGEIA"}]}}}